Papers

2

Total Citations

38

H-Index

2

About

Dr. Andrew Bachman is a surgical oncologist whose research focuses on advancing the surgical management of urologic and gynecologic malignancies, with a particular emphasis on optimizing patient outcomes through comparative effectiveness research. His most influential work, a 2017 study utilizing the National Cancer Database, examined trends in minimally invasive versus open cystectomy for bladder cancer, providing critical insights into the demographic and clinical predictors driving surgical approach selection. This landmark analysis, which has garnered 35 citations, has helped shape contemporary understanding of how patient characteristics influence treatment patterns in complex pelvic surgery. Dr. Bachman has also contributed to the rare disease literature, authoring what is believed to be the first case report of metastatic endometrial serous carcinoma to the ureteral and renal pelvic urothelium—a finding of significant clinical importance given the diagnostic challenges posed by such unusual metastatic patterns. His work bridges the gap between large-scale database analyses and the nuanced management of exceptional clinical presentations, demonstrating a commitment to both population-level surgical trends and the individualized care of patients with rare metastatic disease.

Research Focus

Key Achievements

2
H-Index
2
Papers
38
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database
35 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Oklahoma Health Sciences Center, UConn Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago